Protocol H8H-MC-LAIJ, Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks

The objective of this Phase 3 study is to evaluate the efficacy of lasmiditan 200 mg and 100 mg on migraine headache pain freedom compared to placebo.

Sponsor(s)
Eli Lilly and Company
Principal Investigator(s)
Amanda Tinsley, MD
Contact Phone Number
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

4 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.